Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-24 @ 7:52 PM
NCT ID:
NCT01821404
Eligibility Criteria:
Inclusion Criteria:
* Prostate cancer proven histologically in prostate biopsy
* Radical prostatectomy selected as the first-line treatment
* Willingness to participate and sign informed consent
Exclusion Criteria:
* Previous oncological treatments for any malignancy
* Previous usage of statins, finasteride or dutasteride within a year prior to prostate cancer diagnosis
* Clinically significant liver- or kidney insufficiency (plasma alanine aminotransferase level is twice over the recommended upper limit or serum creatinine level is over 170 µmol/l)
* Previous adverse effects from cholesterol-lowering treatment
* Ongoing use of drugs having interactions with statins (St John's Wort, HIV protease inhibitors, ciclosporin, macrolide antibiotics, fusidic acid, phenytoin, carbamazepine, dronedarone or oral antifungal medication)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01821404
Study Brief:
Protocol Section:
NCT01821404